USING AI MULTIPLEX BIOMARKER ANALYSIS FOR DEEPER INSIGHTS INTO THE TUMOR MICROENVIRONMENT
March 20, 2019 | (9.00 AM)
USA (United States of America)
The interaction of tumor cells and the tumor microenvironment (TME) is a highly complex, heterogeneous system, and individual for each patient. Multiple biomarkers can help improve our understanding, but current standard analysis tests are limited by the insights they can reveal. A tissue-based, multiplex immunohistochemistry (IHC) approach can deliver comprehensive profiling with the help of advanced technology in artificial intelligence (AI). In this webinar, participants will learn from three case studies using various AI-based approaches to gain insights from multi-biomarker analysis. In the first, an improved signature discovery observed with a unique biomarker combination with be discussed, followed by a panel study of seven standardized multiplexed markers that segregate non-small cell lung cancer patients into six categories and describes different immune profiles. The last study on prostate cancer shows how integrating multiplex IHC image analysis with genomic information improves patient stratification.